Artelo Biosciences, Inc. (ARTL): Price and Financial Metrics

Artelo Biosciences, Inc. (ARTL): $1.15

0.04 (+3.60%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add ARTL to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#379 of 473

in industry

ARTL Price/Volume Stats

Current price $1.15 52-week high $1.75
Prev. close $1.11 52-week low $1.00
Day low $1.12 Volume 22,100
Day high $1.18 Avg. volume 34,335
50-day MA $1.15 Dividend yield N/A
200-day MA $1.33 Market Cap 3.71M

ARTL Stock Price Chart Interactive Chart >


Artelo Biosciences, Inc. (ARTL) Company Bio


Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1 clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is headquartered in La Jolla, California.


ARTL Latest News Stream


Event/Time News Detail
Loading, please wait...

ARTL Latest Social Stream


Loading social stream, please wait...

View Full ARTL Social Stream

ARTL Price Returns

1-mo -5.74%
3-mo -10.16%
6-mo -20.14%
1-year -5.44%
3-year -89.26%
5-year -97.29%
YTD -17.86%
2023 -51.56%
2022 -62.88%
2021 -28.90%
2020 -72.96%
2019 -60.87%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!